StockDriftsStockDriftsTop 6 Atlas Venture Life Science Advisors, LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | 48.26% | 4.58M | $381.3M | -1.76%(-81.87K) | $61.12(+85.73%) | 2026-03-31 | |
| DYN | Dyne Therapeutics, Inc. | 20.95% | 9.13M | $165.5M | +0.00%(+0) | $14.26(+61.78%) | 2026-03-31 | |
| SION | Sionna Therapeutics, Inc. | 15.2% | 3.00M | $120.1M | +0.00%(+0) | $10.46(+320.55%) | 2026-03-31 | |
| IRON | Disc Medicine, Inc. | 12.25% | 1.51M | $96.8M | +0.00%(+0) | $36.24(+110.44%) | 2026-03-31 | |
| QTTB | Q32 Bio, Inc. | 1.7% | 2.09M | $13.4M | +0.00%(+0) | $13.99(-6.45%) | 2026-03-31 | |
| KRRO | Korro Bio, Inc. | 1.63% | 1.14M | $12.9M | +0.00%(+0) | $33.67(-58.42%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +27.07% | +105.16% |
| Top 20 Holdings Unweighted | +45.81% | +210.02% |
Sign up free to track Atlas Venture Life Science Advisors, LLC, compare funds side by side, and get alerts the moment positions change.